Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minming Li

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Translational Research|July 18, 2019
Co-occurrence of RUNX1 and ASXL1 mutations underlie poor response and outcome for MDS patients treated with HMAsPing Wu, Jianyu Weng, Minming Li, et al.
Cancer Cell International|October 9, 2015
Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemiaXin Huang, Suxia Geng, Jianyu Weng, et al.
Leukemia Research|March 19, 2016
Effects of the combination of decitabine and homoharringtonine in SKM-1 and Kg-1a cellsSuxia Geng, Han Yao, Jianyu Weng, et al.
Cell Death & Disease|December 2, 2016
Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantationHuijie Jia, Tiesuo Zhao, Yinghua Ji, et al.
Frontiers in Oncology|April 19, 2021
Decitabine With or Without Micro-Transplantation for the Treatment of Intermediate or High-Risk Myelodysplastic Syndrome: A Chinese Single-Center Retrospective Study of 22 PatientsMinMing Li, Chao Li, SuXia Geng, et al.
American Journal of Translational Research|August 10, 2019
A retrospective study comparing azacitidine with decitabine in Chinese patients with refractory anemia with excess blast based on two clinical trials in a single centerRuohao Xu, Xiaomei Chen, Chengxin Deng, et al.
Frontiers in Immunology|August 25, 2022
Dynamics of PD-1 expression are associated with treatment efficacy and prognosis in patients with intermediate/high-risk myelodysplastic syndromes under hypomethylating treatmentSuxia Geng, Ruohao Xu, Xin Huang, et al.
American Journal of Cancer Research|May 5, 2021
Concurrence of Myelodysplastic syndromes and large granular lymphocyte leukemia: clinicopathological features, mutational profile and gene ontology analysis in a single centerKexin Ai, Minming Li, Ping Wu, et al.
Frontiers in Cell and Developmental Biology|February 7, 2022
Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid LeukemiaJinghua Wang, Zewei Zhuo, Yanjun Wang, et al.
British Journal of Haematology|May 7, 2021
Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypesRuohao Xu, Xin Huang, Chao Li, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Translational Research|July 18, 2019
Co-occurrence of RUNX1 and ASXL1 mutations underlie poor response and outcome for MDS patients treated with HMAsPing Wu, Jianyu Weng, Minming Li, et al.
Cancer Cell International|October 9, 2015
Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemiaXin Huang, Suxia Geng, Jianyu Weng, et al.
Leukemia Research|March 19, 2016
Effects of the combination of decitabine and homoharringtonine in SKM-1 and Kg-1a cellsSuxia Geng, Han Yao, Jianyu Weng, et al.
Cell Death & Disease|December 2, 2016
Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantationHuijie Jia, Tiesuo Zhao, Yinghua Ji, et al.
Frontiers in Oncology|April 19, 2021
Decitabine With or Without Micro-Transplantation for the Treatment of Intermediate or High-Risk Myelodysplastic Syndrome: A Chinese Single-Center Retrospective Study of 22 PatientsMinMing Li, Chao Li, SuXia Geng, et al.
American Journal of Translational Research|August 10, 2019
A retrospective study comparing azacitidine with decitabine in Chinese patients with refractory anemia with excess blast based on two clinical trials in a single centerRuohao Xu, Xiaomei Chen, Chengxin Deng, et al.
Frontiers in Immunology|August 25, 2022
Dynamics of PD-1 expression are associated with treatment efficacy and prognosis in patients with intermediate/high-risk myelodysplastic syndromes under hypomethylating treatmentSuxia Geng, Ruohao Xu, Xin Huang, et al.
American Journal of Cancer Research|May 5, 2021
Concurrence of Myelodysplastic syndromes and large granular lymphocyte leukemia: clinicopathological features, mutational profile and gene ontology analysis in a single centerKexin Ai, Minming Li, Ping Wu, et al.
Frontiers in Cell and Developmental Biology|February 7, 2022
Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid LeukemiaJinghua Wang, Zewei Zhuo, Yanjun Wang, et al.
British Journal of Haematology|May 7, 2021
Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypesRuohao Xu, Xin Huang, Chao Li, et al.
Pageof 4